angiolight

MicroRNAs (miRNAs) are pivotal players in cellular processes including cell cycle regulation, apoptosis, differentiation, metabolism, immune response, and tissue development. Enhanced understanding of their functions is crucial since dysregulation of miRNA expression is associated with various diseases, including cancer, cardiovascular disorders, and neurological conditions. Therefore, identifying and validating miRNA targets not only sheds light on their biological roles but also contributes to therapeutic advancements.

The Importance of Validation in miRNA Research

While computational algorithms and databases assist in predicting miRNA binding sites, their predictions often suffer from high false-positive rates. This is where experimental validation becomes essential. The luciferase reporter assay stands out as one of the most reliable methods for confirming miRNA-target interactions. This assay is characterized by its sensitivity, quantitative resolution, and relatively rapid execution.

The miRNA Luciferase Reporter Assay: A Closer Look

The principle of the miRNA luciferase reporter assay involves placing a gene segment containing the predicted miRNA binding site downstream of a luciferase gene within a plasmid. This plasmid, when transfected into cells, allows endogenous miRNA to inhibit luciferase translation or degrade its mRNA. The outcome is a measurable decrease in luminescence, confirming the interaction between miRNA and its target.

Workflow Overview
  • Cloning of predicted binding sites into the luciferase reporter gene to create wild-type and mutant versions.
  • Co-transfection of wild-type and mutant constructs along with miRNA mimics or inhibitors into mammalian cell lines.
  • Measurement of luciferase activity, providing insights into the binding interactions.
  • Use of an additional luciferase gene as an internal control to enhance accuracy regarding transfection efficiency and cell variability.
Our Comprehensive Service Offer

IntegrateRNA offers a thorough miRNA luciferase reporter assay service designed for precision and efficiency in validating miRNA targets. Our experienced team of molecular biologists utilizes advanced platforms and refined workflows to ensure high-quality and reproducible results.

Service Package Includes:
  • In silico Target Prediction: Prioritization of potential binding sites using computational tools.
  • Cell Line Selection & Transfection: Utilization of optimized mammalian cell lines alongside miRNA mimics or NC mimics during transfection.
  • Luciferase Activity Detection: Implementation of sensitive dual-luciferase assays for accurate quantification of reporter activity.
  • Data Analysis & Reporting: Comprehensive reports detailing raw data, graphical representations, interpretations, and conclusions.
Applications of the miRNA Luciferase Reporter Assay

The versatility of our miRNA luciferase reporter assay service allows it to be applied across various research domains:

  • Validation of predicted miRNA target genes.
  • Identification and functional confirmation of binding sites.
  • Investigation of transcript stability and translation regulation.
  • Mechanistic studies in disease models such as oncology, cardiology, and immunology.
Advantages of Choosing IntegrateRNA
  • High Sensitivity and Specificity: Utilizing dual-luciferase reporter systems adds robustness.
  • Customizable Solutions: Flexible options for experimental conditions, allowing for tailored approaches.
  • Publication-Ready Data: Results are formatted for easy integration into research submissions and presentations.
  • Cost-Effective Options: Our pricing structures aim to support research budgets without compromising quality.
How to Get Started

Prospective clients are encouraged to submit details regarding their miRNA of interest, including the sequence and any specific project requirements. This will facilitate an efficient and smooth initiation of services.

User interests